U.S. IPO Week Ahead: Healthcare And Micro-Caps Dominate Week With Up To 8 IPOs
U.S. IPO Week Ahead: Healthcare And Micro-Caps Dominate Week With Up To 8 IPOs.....»»
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»
Take Five: Vol squall coming? World markets themes for the week ahead
Following are five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them......»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»
Take Five: Dollar darling. World markets themes for the week ahead
Following are five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them......»»
Clouds Part: Amazon And Microsoft Cloud Businesses In Focus Ahead Of Earnings
Two U.S. companies arguably dominate the growing cloud infrastructure, and they both report later this week even as they wrestle each other to be the second highest-valued stock by market capitalization. read more.....»»
Clouds Part: Amazon And Microsoft Cloud Businesses In Focus Ahead Of Earnings
Two U.S. companies arguably dominate the growing cloud infrastructure, and they both report later this week even as they wrestle each other to be the second hi.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter.....»»
Cramer"s game plan: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnings and stock trading......»»
Cramer: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnuings and stock trading......»»
Stocks erase weekly gains on lackluster manufacturing data
A gauge of global stocks erased this week's gains on Thursday after underwhelming manufacturing surveys from Asia and Europe and continued weakness in U.S. healthcare shares spurred profit-taking ahead of an extended Easter holiday weekend......»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs.....»»
US IPO Week Ahead: Pinterest and Zoom headline year"s busiest week with 8 IPOs
A whopping eight IPOs plan.....»»
Take Five: Wall Street calling! World market themes for the week ahead
Following are five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them......»»
Take Five: Panic over? World markets themes for the week ahead
Following are the five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them......»»
Take Five: The shape of you - world market themes for the week ahead
Following are five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them......»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Biotech stocks came under pressure last week despite two FDA approvals coming through. read more.....»»